Skip to content
ViraxImmune™
Media
Leadership
Contact
Investor Relations
ViraxImmune™
Media
Leadership
Contact
Investor Relations
VRAX: INITIATION: Innovative Biotechnology Company Developing A Potentially Groundbreaking Immunology Platform Based Around Proprietary T-Cell Testing Technology
February 16 2023
Read the Report Here
by Thomas Kerr, CFA